[en] Introduction/Objective The Sarcopenia Quality of Life (SarQoL®) questionnaire is a patient-reported
outcome measure specific to sarcopenia.
The objective was to translate the SarQoL® questionnaire from English into Serbian and to investigate
its psychometric performance.
Methods A five-stage forward-backward methodology with pre-test was used to translate the questionnaire.
The validation sample in this study consisted of elderly, community-dwelling volunteers of both
sexes. Three methods were used to screen for and diagnose sarcopenia: the SARC-F questionnaire (high/
low risk), low handgrip strength [probable sarcopenia in the European Working Group on Sarcopenia
in Older People (EWGSOP2) algorithm], and the complete EWGSOP2 criteria. We investigated the questionnaire’s
discriminative power, internal consistency, construct validity, and floor and ceiling effects.
Results The SarQoL® questionnaire was translated into Serbian. The validation study included 699 participants.
In total, 200 participants were considered to be at high risk of sarcopenia by the SARC-F, 84
were diagnosed with low handgrip strength and 12 were confirmed to be sarcopenic. We did not find
significantly lower overall QoL scores using the EWGSOP2 criteria (60.31 vs. 64.60; p = 0.155). We did
find lower scores for the probably sarcopenic group (52.80 vs. 65.50; p < 0.001) and the high-risk group
(50.91 vs. 69.02; p < 0.001). The Cronbach’s α coefficient was 0.87, indicating a high internal consistency.
Construct validity was adequate, with 75% of hypotheses on expected correlations with the SF-36 and
EQ-5D questionnaires confirmed. No floor or ceiling effects were observed.
Conclusion We successfully translated the SarQoL® into Serbian, and showed that it is a valid tool for
measuring QoL in the community-dwelling elderly.
Disciplines :
Public health, health care sciences & services
Author, co-author :
Matijević, Radmila
Hrnjaković, Olivera
Đurđević, Aleksa
Geerinck, Anton ; Université de Liège - ULiège > Département des sciences de la santé publique > Santé publique, Epidémiologie et Economie de la santé
Beaudart, Charlotte ; Université de Liège - ULiège > Département des sciences de la santé publique > Santé publique, Epidémiologie et Economie de la santé
Bruyère, Olivier ; Université de Liège - ULiège > Département des sciences de la santé publique > Santé publique, Epidémiologie et Economie de la santé
Dulić, Oliver
Harhaji, Vladimir
Rašović, Predrag
Language :
English
Title :
Translation and psychometric performance of the Serbian version of the Sarcopenia Quality of Life (SarQoL®) questionnaire
scite shows how a scientific paper has been cited by providing the context of the citation, a classification describing whether it supports, mentions, or contrasts the cited claim, and a label indicating in which section the citation was made.
Bibliography
Cruz-Jentoft A, Baeyens J, Bauer J, Boirie Y, Cederholm T, Landi F, et al. Sarcopenia: European consensus on definition and diagnosis. Age Ageing. 2010;39(4):412–23.
Cruz-Jentoft A, Bahat G, Bauer J, Boirie Y, Bruyère O, Cederholm T, et al. Sarcopenia: revised European consensus on definition and diagnosis. Age Ageing. 2019;48(1):16–31.
Beaudart C, McCloskey E, Bruyère O, Cesari M, Rolland Y, Rizzoli R, et al. Sarcopenia in daily practice: assessment and management. BMC Geriatr. 2016;16(1):170.
Shafiee G, Keshtkar A, Soltani A, Ahadi Z, Larijani B, Heshmat R. Prevalence of sarcopenia in the world: a systematic review and meta-analysis of general population studies. J Diabetes Metab Disord. 2017;16:16:21.
United Nations. World Population Ageing. Population Division, Department of Economic and Social Affairs; 2019.
Ethgen O, Beaudart C, Buckinx F, Bruyère O, Reginster JY. The Future Prevalence of Sarcopenia in Europe: A Claim for Public Health Action. Calcif Tissue Int. 2017;100(3):229–34.
Jakovljevic M. Population ageing alongside health care spending growth. Srpski arhiv za celokupno lekarstvo. 2017;145(9–10):113– 29.
Geerinck A, Bruyère O, Locquet M, Reginster J, Beaudart C. Evaluation of the Responsiveness of the SarQoL® Questionnaire, a Patient-Reported Outcome Measure Specific to Sarcopenia. Adv Ther. 2018;35(11):1842–58.
Beaudart C, Biver E, Reginster JY, Rizzoli R, Rolland Y, Bautmans I, et al. Development of a self-administrated quality of life questionnaire for sarcopenia in elderly subjects: the SarQoL. Age Ageing. 2015;44(6):960–6.
The SarQoL questionnaire [Internet]. [Online]. [cited 2020 February 16]. Available from: http://www.sarqol.org.
Beaudart C, Biver E, Reginster J, Rizzoli R, Rolland Y, Bautmans I, et al. Validation of the SarQoL®, a specific health‐related quality of life questionnaire for Sarcopenia. J Cachexia Sarcopenia Muscle. 2017;8(2):238–44.
Beaudart C, Edwards M, Moss C, Reginster J, Moon R, Parsons C, et al. English translation and validation of the SarQoL®, a quality of life questionnaire specific for sarcopenia. Age Ageing. 2017;46(2):271–6.
Gasparik A, Mihai G, Beaudart C, Bruyere O, Pop R, Reginster J, et al. Psychometric performance of the Romanian version of the SarQoL®, a health-related quality of life questionnaire for sarcopenia. Arch Osteoporos. 2018;13(1):98.
Hodinka L, Vereckei E, Gasparik A. Sarcopenia and quality of life: the validated Hungarian translation of the Sarcopenia Quality of Life (SarQoL) questionnaire. Orv Hetil. 159(36):1483–6.
Konstantynowicz J, Abramowicz P, Glinkowski W, Taranta E, Marcinowicz L, Dymitrowicz M, et al. Polish Validation of the SarQoL®, a Quality of Life Questionnaire Specific to Sarcopenia. J Clin Med. 2018;7(10):323.
Tsekoura M, Billis E, Gliatis J, Tsepis E, Matzaroglou C, Sakkas G, et al. Cross cultural adaptation of the Greek sarcopenia quality of life (SarQoL) questionnaire. Disabil Rehabil. 2020;42(7):1006–12.
Geerinck A, Scheppers A, Beaudart C, Bruyère O, Vandenbussche W, Bautmans R, et al. Translation and validation of the Dutch SarQoL®, a quality of life questionnaire specific to sarcopenia. J Musculoskelet Neuronal Interact. 2018;18(4):463–72.
Fábrega-Cuadros R, Martínez-Amat A, Cruz-Díaz D, Aibar-Almazán A, Hita-Contreras F. Psychometric Properties of the Spanish Version of the Sarcopenia and Quality of Life, a Quality of Life Questionnaire Specific for Sarcopenia. Calcif Tissue Int. 2020;106(3):274–82.
Alekna V, Kilaite J, Tamulaitiene M, Geerinck A, Mastaviciute A, Bruyère O, et al. Validation of the Lithuanian version of sarcopenia-specific quality of life questionnaire (SarQoL®). Eur Geriatr Med. 2019;10:761–7.
Safonova Y, Lesnyak O, Baranova I, Suleimanova A, Zotkin E. Russian translation and validation of SarQoL® – quality of life questionnaire for patients with sarcopenia. Rheumatology Science and Practice. 2019;57(1):38–45.
Beaton D, Bombardier C, Guillemin F, Ferraz M. Guidelines for the process of crosscultural adaptation of self-report measures. Spine (Phila Pa 1976). 2000;25(24):3186–91.
Malmstrom T, Morley J. SARC-F: a simple questionnaire to rapidly diagnose sarcopenia. J Am Med Dir Assoc. 2013;14(8):531–2.
Roberts H, Denison H, Martin H, Patel H, Syddall H, Cooper C, et al. A review of the measurement of grip strength in clinical and epidemiological studies: towards a standardised approach. Age Ageing. 2011;40(4):423–9.
Terwee C, Bot S, de Boer M, van der Windt D, Knol D, Dekker J, et al. Quality criteria were proposed for measurement properties of health status questionnaires. J Clin Epidemiol. 2007;60(1):34–42.
Karran J, Moodie E, Wallace M. Statistical method use in public health research. Scand J Public Health. 2015;43(7):776–82.
Cruz-Jentoft A, Landi F, Schneider S, Zúñiga C, Arai H, Boirie Y, et al. Prevalence of and interventions for sarcopenia in ageing adults: a systematic review. Report of the International Sarcopenia Initiative (EWGSOP and IWGS). Age Ageing. 2014;43(6):748–59.
Lu JL, Ding LY, Xu Q. Screening Accuracy of SARC-F for Sarcopenia in the Elderly: A Diagnostic Meta-Analysis. J Nutr Health Aging (2020).
This website uses cookies to improve user experience. Read more
Save & Close
Accept all
Decline all
Show detailsHide details
Cookie declaration
About cookies
Strictly necessary
Performance
Strictly necessary cookies allow core website functionality such as user login and account management. The website cannot be used properly without strictly necessary cookies.
This cookie is used by Cookie-Script.com service to remember visitor cookie consent preferences. It is necessary for Cookie-Script.com cookie banner to work properly.
Performance cookies are used to see how visitors use the website, eg. analytics cookies. Those cookies cannot be used to directly identify a certain visitor.
Used to store the attribution information, the referrer initially used to visit the website
Cookies are small text files that are placed on your computer by websites that you visit. Websites use cookies to help users navigate efficiently and perform certain functions. Cookies that are required for the website to operate properly are allowed to be set without your permission. All other cookies need to be approved before they can be set in the browser.
You can change your consent to cookie usage at any time on our Privacy Policy page.
